Company intelligence / Profile preview

Bard Cancer Diagnostics

Ownership
Private
Development stage
Commercial
01

Overview

Bard Cancer Diagnostics is a specialized medical facility in New York City focused on advanced, non-invasive cancer imaging and early detection. Founded by Dr. Robert L. Bard, the center utilizes cutting-edge technologies such as 3D/4D Doppler ultrasound, elastography, and MRI to provide high-resolution analysis of tumors in the prostate, breast, skin, and thyroid. By focusing on blood flow (angiogenesis) and tissue stiffness, the practice offers "digital biopsy" alternatives to traditional invasive procedures. Bard Cancer Diagnostics is recognized for its expertise in monitoring treatment efficacy and its commitment to personalized cancer prevention and functional health.

Therapeutic areas
Oncology
Modalities
DeviceNon-pharmacological therapy
Industry
Non-Academic Healthcare
02

Drug pipeline

1 asset

Pro-Rose Plus

Commercial
Indications
Cancer prevention, General health maintenance
03

Partnerships

NY Cancer Resource AllianceThe Biofoundation for Angiogenesis Research and Development

Beyond the preview

Go deeper on Bard Cancer Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bard Cancer Diagnostics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call